No Products in the Cart
Sourced from bovine bone mineral and manufactured through a distinctive process, Ousia™ bioXEN bone grafting particulate has the crystalline structure of carbonate apatite, much like the structure of intact human bone. Ousia™ bioXEN allows for a blend of a porous structure for vascular access with a roughened surface that is advantageous to cell adhesion and subsequent bone matrix deposition.
An Osteoconductive Matrix
Surgeons have a biocompatible and safe osteoconductive matrix used for new bone formation in defects.
Ousia™ bioXEN indications:
Ousia™ bioXEN benefits:
bioXEN and Bio-Oss® sections taken at 2 months show residual implant material present within the defects. The histology images shown below refer to new bone in apposition to the bioXEN or Bio-Oss® bone mineral matrix. New bone (green) can also be seen adjacent to the mineral, showing evidence of ongoing bone formation in the defect area.
Histological Assessment at 8 weeks (Based on Histology Scores 1-5)
Residual Implant Material
Ousia™ bioXEN Histology
In vivo studies comparing Ousia™ bioXEN and Bio-Oss® show similarities in performance of these products. In this study, there were no significant differences between the two products.
Bio-Oss® is a registered trademark of Geistlich, Wolhusen, Switzerland.
|Color:||Blue, Purple, White|